Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Salarius Pharmaceuticals, Inc. (FLKS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/11/2020 |
8-K/A
| Financial Statements and Exhibits |
| 09/18/2019 |
8-K/A
| Asset disposition|
Docs:
|
"Consent of Weaver and Tidwell, L.L.P",
"Audited Financial Statements of Salarius Pharmaceuticals, LLC for the years ended December 31, 2018 and 2017",
"Unaudited Financial Statements of Salarius Pharmaceuticals, LLC for the six months ended June 30, 2019 and 2018",
"Unaudited Pro Forma Condensed Combined Balance Sheet and Statement of Operations of the Company for the six months ended June 30, 2019 and Condensed Combined Statement of Operations for the year ended December 31, 2018",
"Unaudited Financial Statements of Salarius Pharmaceuticals, LLC for the three months ended March 31, 2019 and 2018" |
|
| 06/20/2018 |
8-K/A
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 06/10/2016 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 12/22/2015 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/02/2015 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|